Cargando…

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir

The aim of this report is to review the literature and shed light on the uncertainties surrounding the use of antiviral agents in general and remdesivir in COVID-19 patients. This review evaluated a battery of antiviral compounds and their effectiveness in the treatment of COVID-19 since the beginni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno, Santiago, Alcázar, Bernardino, Dueñas, Carlos, González del Castillo, Juan, Olalla, Julián, Antela, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965332/ https://www.ncbi.nlm.nih.gov/pubmed/35370401 http://dx.doi.org/10.2147/DDDT.S356951

Ejemplares similares

Remdesivir, la esperanza antiviral frente al SARS-CoV-2
por: Reina, Jordi
Publicado: (2020)

A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
por: Simonis, Alexander, et al.
Publicado: (2020)

Antiviral Lipid Nanocarrier Loaded with Remdesivir Effective Against SARS-CoV-2 in vitro Model
por: Jeon, Woo-Jin, et al.
Publicado: (2023)

Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
por: Uzunova, Katya, et al.
Publicado: (2020)

Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
por: Nguyenla, Xammy, et al.
Publicado: (2022)

Early experience with remdesivir in SARS-CoV-2 pneumonia
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2020)

Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
por: Pirzada, Rameez Hassan, et al.
Publicado: (2021)

Effectiveness of Remdesivir in Comparison with Five Approved Antiviral Drugs for Inhibition of RdRp in Combat with SARS-CoV-2
por: Mahdian, Soodeh, et al.
Publicado: (2022)

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)

SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment
por: Lahmer, Tobias, et al.
Publicado: (2022)

Contre Sars-CoV-2, brequinar ou remdesivir ?
por: Manus, Jean-Marie
Publicado: (2021)

Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021)

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
por: Kokic, Goran, et al.
Publicado: (2021)

Enhanced Remdesivir Analogues to Target SARS-CoV-2
por: Majima, Ryuichi, et al.
Publicado: (2023)

Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes
por: Choi, Seong Woo, et al.
Publicado: (2020)

Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2
por: Jang, Yejin, et al.
Publicado: (2021)

Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants
por: Pitts, Jared, et al.
Publicado: (2022)

Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
por: Heyer, Andreas, et al.
Publicado: (2022)

The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models
por: Stegmann, Kim M., et al.
Publicado: (2021)

Remdesivir administration for SARS-CoV-2 pneumonia in ICU and non-ICU patients: outcome and posttreatment differences — the Italian Military Hospital experience
por: Sabba, Antonio, et al.
Publicado: (2023)

Safety profile of the antiviral drug remdesivir: An update
por: Fan, Qianqian, et al.
Publicado: (2020)

Arguments in favour of remdesivir for treating SARS-CoV-2 infections
por: Ko, Wen-Chien, et al.
Publicado: (2020)

Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia()
por: Cacho, Judit, et al.
Publicado: (2022)

Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection
por: Cacho, Judit, et al.
Publicado: (2022)

Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic
por: Poliseno, Mariacristina, et al.
Publicado: (2021)

Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Dobrovolny, Hana M.
Publicado: (2020)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
por: Lo, Ho Sing, et al.
Publicado: (2021)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication
por: Bravo, Jack P.K., et al.
Publicado: (2021)

The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir
por: Zhao, Yan, et al.
Publicado: (2021)

Liver and Renal Injury with Remdesivir Treatment in SARS-CoV-2 Patients
por: Sadaf, Rabiah, et al.
Publicado: (2023)

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
por: Monteil, Vanessa, et al.
Publicado: (2020)

Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection
por: Sanchez-Codez, Maria Isabel, et al.
Publicado: (2021)

SARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context()
por: Isea de la Viña, Jesus, et al.
Publicado: (2020)

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
por: Gonçalves, Antonio, et al.
Publicado: (2020)

Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain
por: Soriano, Alejandro, et al.
Publicado: (2021)

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
por: Petrakis, Vasilis, et al.
Publicado: (2022)

Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
por: Nayeem, Shaik Mahammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eoco455tn9pecs2ju0ioc5i933